As of June 2026 Adaptimmune Therapeutics has a market cap of ยฃ11.02 Million. This makes Adaptimmune Therapeutics the world's 10606th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.